Loading viewer...
investor_presentation
Format: PDF investor_presentation
Fourth Quarter FY’24 Earnings Conference Call Daniel J. Crowley , Chairman, President & CEO James F. McCabe, Jr. , Senior Vice President & CFO
Fourth Quarter FY’24
Earnings Conference Call
Daniel J. Crowley , Chairman, President & CEO
James F. McCabe, Jr. , Senior Vice President & CFOThis presentation contains forward -looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 .Forward -looking
statements are often, but not always, identified by words such as “anticipate”, “believe”, “expect”, “plan”, “intend”, “project” , “may”, “will”, “should”,
“could”, or similar words suggesting future outcomes or outlooks. These forward -looking statements include, but are not limited to, statements of
expectations of or assumptions about strategic actions (including the ability to complete previously announced transactions),
objectives, expectations, intentions, aerospace market conditions, aircraft production rates, financial and operational performa nce, including with
respect to preliminary results of discontinued operations, revenue and earnings growth and profitability and earnings results. T hese statements are
based on the current projections, expectations and beliefs of TRIUMPH’s management. These forward looking statements involve known and
unknown risks, uncertainties and other factors which could cause actual results to differ materially from any expected future results, performance
orachievements, including, but not limited to, competitive and cyclical factors relating to the aerospace industry, dependence on some of
TRIUMPH’s business from key customers, requirements of capital, uncertainties relating to the integration of acquired businesses , general
economic conditions affecting TRIUMPH’s business segments, product liabilities in excess of insurance, technological development s, limited
availability of raw materials or skilled personnel, changes in governmental regulation and oversight, international hostilities and terrorism and
bondholder response to any offer of ours to repurchase their notes. Further information regarding the important factors that could cause actual
results, performance or achievements to differ from those expressed in any forward -looking statements can be found in TRIUMPH’s reports filed
with the SEC, including in the risk factors described in TRIUMPH’s Annual Report on Form 10 -K for the fiscal year ended March 31 , 2023.
The presentation contains Non -GAAP measures. Please see slides titled “Non -GAAP Disclosures” for more information.
TRIUMPH / Q4 FY’24 / May 23, 2024 | 2Forward Looking StatementQ4 FY’24 Takeaways and Full Year Business Mix
63%Non-Aviation 6%FY24 Sales by End Market
FY24 Relative Profit
Note: Operating companies presented in the chart based on relative net sales contribution.✓Product Support sale complete
✓Deleveraged from 7.6x to 4.9x two plus years early
✓Non-aviation sales now 5%
Strong finish to the year; Balance Sheet actions derisk multi -year forecast
•Aftermarket 34% of sales
TRIUMPH / Q4 FY’24 / May 23, 2024 | 3Top 5 Programs in backlog growing
Profitability of backlog improving
Long Term Rate Trend
Preview truncated — download the full document for the complete content.
investor_presentation
25 Pages
investor_presentation
17 Pages
Helen of Troy Limited
Tonix Pharmaceuticals Holding Investor Presentation — February 2018
investor_presentationinvestor_presentation
35 Pages
Tonix Pharmaceuticals Holding Corp.